Sabrina H Tsang1, M Larissa Avilés-Santa2, Christian C Abnet3, Maximo O Brito4, Martha L Daviglus5, Sylvia Wassertheil-Smoller6, Sheila F Castañeda7, Sharon Minnerath8, Gregory A Talavera7, Barry I Graubard3, Bharat Thyagarajan8, M Constanza Camargo3. 1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. Electronic address: s.tsang0323@gmail.com. 2. Division on Clinical and Health Services Research, National Institute on Health and Health Disparities, Rockville, Maryland. 3. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. 4. Division of Infectious Diseases, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois. 5. Institute for Minority Health Research, University of Illinois at Chicago, Chicago, Illinois. 6. Albert Einstein College of Medicine, Yeshiva University, Bronx, New York. 7. Department of Psychology, San Diego State University, San Diego, California. 8. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.
Abstract
BACKGROUND & AIMS: Helicobacter pylori infection is the primary known risk factor for gastric cancer. Despite the global decline in H. pylori prevalence, this infection remains a major public health concern in developing areas, including Latin America. Our study aimed to determine H. pylori seroprevalence and identified its determinants among Hispanics/Latinos living in the United States (U.S.). METHODS: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) is a population-based sample of self-identified Hispanics/Latinos (n = 16,144) in four U.S. communities, aged 18 to 74 years, recruited from randomly selected households using a stratified two-stage area probability sample design based on sampling households within sampled census block groups weighted for differential response rates. Anti-H. pylori immunoglobulin G antibodies were measured by an enzyme-linked immunosorbent assay using plasma samples. We calculated adjusted seroprevalence (i.e., predicted margins) from multivariable logistic regression models. RESULTS: The overall weighted H. pylori seroprevalence was 57% among HCHS/SOL participants, with 38% and 62% seropositivity among U.S.-born and non-U.S.-born individuals, respectively. Age-adjusted prevalence varied by self-reported Hispanic/Latino background, ranging from 47% in Puerto Rican to 72% in Central American backgrounds. Adjusted H. pylori seroprevalence was higher in the following groups: older age, male sex, lower education, non-U.S. born status, smoking, greater number of missing teeth, fewer doctor visits, lower ferritin level, and hepatitis A seropositivity. CONCLUSIONS: H. pylori seroprevalence in Hispanics/Latinos remains high and differed significantly by Hispanic/Latino background. H. pylori seropositivity is strongly associated with poor socioeconomic conditions. These findings highlight the ongoing importance of this bacterial infection in the U.S. Published by Elsevier Inc.
BACKGROUND & AIMS: Helicobacter pylori infection is the primary known risk factor for gastric cancer. Despite the global decline in H. pylori prevalence, this infection remains a major public health concern in developing areas, including Latin America. Our study aimed to determine H. pylori seroprevalence and identified its determinants among Hispanics/Latinos living in the United States (U.S.). METHODS: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) is a population-based sample of self-identified Hispanics/Latinos (n = 16,144) in four U.S. communities, aged 18 to 74 years, recruited from randomly selected households using a stratified two-stage area probability sample design based on sampling households within sampled census block groups weighted for differential response rates. Anti-H. pylori immunoglobulin G antibodies were measured by an enzyme-linked immunosorbent assay using plasma samples. We calculated adjusted seroprevalence (i.e., predicted margins) from multivariable logistic regression models. RESULTS: The overall weighted H. pylori seroprevalence was 57% among HCHS/SOL participants, with 38% and 62% seropositivity among U.S.-born and non-U.S.-born individuals, respectively. Age-adjusted prevalence varied by self-reported Hispanic/Latino background, ranging from 47% in Puerto Rican to 72% in Central American backgrounds. Adjusted H. pylori seroprevalence was higher in the following groups: older age, male sex, lower education, non-U.S. born status, smoking, greater number of missing teeth, fewer doctor visits, lower ferritin level, and hepatitis A seropositivity. CONCLUSIONS: H. pylori seroprevalence in Hispanics/Latinos remains high and differed significantly by Hispanic/Latino background. H. pylori seropositivity is strongly associated with poor socioeconomic conditions. These findings highlight the ongoing importance of this bacterial infection in the U.S. Published by Elsevier Inc.
Authors: Ilseung Cho; Martin J Blaser; Fritz François; Jomol P Mathew; Xiang Y Ye; Judith D Goldberg; Edmund J Bini Journal: Am J Epidemiol Date: 2005-08-10 Impact factor: 4.897
Authors: Lisa M Lavange; William D Kalsbeek; Paul D Sorlie; Larissa M Avilés-Santa; Robert C Kaplan; Janice Barnhart; Kiang Liu; Aida Giachello; David J Lee; John Ryan; Michael H Criqui; John P Elder Journal: Ann Epidemiol Date: 2010-08 Impact factor: 3.797
Authors: Carolina Porras; Jesse Nodora; Rachael Sexton; Catterina Ferreccio; Silvia Jimenez; Ricardo L Dominguez; Paz Cook; Garnet Anderson; Douglas R Morgan; Laurence H Baker; E Robert Greenberg; Rolando Herrero Journal: Cancer Causes Control Date: 2012-12-12 Impact factor: 2.506
Authors: Rohina Rubicz; Charles T Leach; Ellen Kraig; Nikhil V Dhurandhar; Barry Grubbs; John Blangero; Robert Yolken; Harald Hh Göring Journal: BMC Res Notes Date: 2011-10-21